Pharmacy

The FINANCIAL -- Novo Nordisk on January 8 confirms that it made a proposal on 22 December 2017 to acquire Ablynx for EUR 28.00 per share in cash and one CVR with total potential cash payments over time of up to EUR 2.50 per ...

More Articles ...

More Articles ...

The FINANCIAL -- Merck on November 28 announced that the Board of Directors has increased the company’s quarterly dividend to $0.48 per outstanding share of the company’s common stock, up $0.01 ...

The FINANCIAL -- Takeda Pharmaceutical Company Limited on January 5 announced its intention to acquire TiGenix NV, an advanced biopharmaceutical company developing novel stem cell therapies for ...

The FINANCIAL -- Novartis announced on December 15 that Bruno Strigini, CEO Novartis Oncology has decided to retire from Novartis and the industry for personal ...

The FINANCIAL -- Bayer announced on December 13 that the Chinese Food and Drug Administration (CFDA) approved Stivarga (regorafenib) tablets for the second-line treatment of patients with ...

Videos

Watch the video